Skip to main content
Premium Trial:

Request an Annual Quote

Waters Q3 Revenues Up, Income Down

NEW YORK, Oct. 22 (GenomeWeb News) - Waters reported revenues of $230.4 million for the third quarter today, up from $216.0 million for the same period last year.

 

The Milford, Mass., instruments company had net income of $36.4 million, compared to $39.0 million for the same period last year.

 

For the quarter, R&D expenses increased to $15.1 million, from $13.6 million in the same period last year.

 

The company said its results for the quarter include "restructuring and other incremental costs and adjustments recorded in relation to the Company's reorganization of the HPLC and mass spectrometry businesses, and restructuring charges relating to the acquisition of the rheology business of Rheometric Scientific." Additionally, they reflect charges for in-process R&D that relate to the acquisition of Creon Lab Control, the company said.

 

As of Sept. 30, Waters had $288.1 million in cash and cash equivalents, up from $263.3 million at the end of 2002.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.